Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy (NCT07502508)
Phase 2 Randomized, Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Icovamenib in Participants With Type 2 Diabetes Not Achieving Glycemic Targets Despite GLP-1-Based Therapy
🩺 Plain-English Summary (8th-Grade Level)
This is a phase 2 randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes (T2D) not achieving glycemic targets despite Ozempic-based therapy.
Who can join: Review the eligibility criteria below.
Location: Central Research Associates, LLC dba Flourish Research — Birmingham, Alabama
Age range: 18 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (17 Sites)
- Central Research Associates, LLC dba Flourish Research — Birmingham, Alabama
- Hope Clinical Research — Canoga Park, California
- Ark Clinical Research — Long Beach, California
- Catalina Research Institute, LLC — Montclair, California
- Paradigm Clinical Research Centers, LLC — San Diego, California
- Southwest General Healthcare Center — Fort Myers, Florida
- Panax Clinical Research — Miami Lakes, Florida
- Flourish Research Orlando — Winter Park, Florida
- David Kavtaradze MD, Inc — Cordele, Georgia
- Excel Clinical Research — Las Vegas, Nevada
- Diabetes and Endocrinology Associates of Stark County — Canton, Ohio
- Elligo Health Research, Inc. — Austin, Texas
- Zenos Clinical Research — Dallas, Texas
- Synergy Group Medical — Houston, Texas
- Epic Clinical Research — Lewisville, Texas
- Diabetes & Glandular Disease Clinic, P.A. — San Antonio, Texas
- Burke Internal Medicine and Research — Burke, Virginia
📞 Contact the Study Coordinator
Phone: (844) 245-0490
Email: clinicaltrials@biomeafusion.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Type 2 Diabetes
- Continuous Glucose Monitoring System Feasibility in Youth With T2D — San Francisco, California
- Diabetes Nutrition Education and Healthy Food Resource for AIANs With T2D — Oklahoma City, Oklahoma
- Personalized Nutrition Therapy Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus — Minneapolis, Minnesota
- Diabetes Medical Nutrition Therapy in Southeastern African American Women — Nashville, Tennessee
- E3 Diabetes - Closing the Gap in Diabetes Control — Chicago, Illinois
- Recreational Basketball to Increase Participation in Diabetes Prevention — Atlanta, Georgia
Explore by condition: All Type 2 Diabetes clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.